Susan Chapelle

Health Canada Considers MDMA And Psilocybin 'Special Access' Program This week, Health Canada opened a public consultation on its “proposal to restore potential access to restricted drugs through the Special Access Program (SAP).” The SAP allows healthcare professionals to...

In recent years mushrooms left their dark, hidden habitats to jump into the spotlight of consumer markets. A hunger for natural foods and wellness products propelled consumers to explore the realm of fungi as a source of nutrition and wellness, as well as a means to achieving physical and mental...

Havn Life Goes Public on CSE and Announces Authorization for Research  Havn Life Sciences Inc. (CSE : HAVN), a recently-formed psychedelics company, announced on Tuesday its debut on the Canadian Securities Exchange under the symbol HAVN. The company is led by co-CEOs Susan Chapelle and Tim...

Havn Life Sciences Inc. (CSE : HAVN), a recently-formed psychedelics company, announced on Tuesday its debut on the Canadian Securities Exchange under the symbol HAVN. The company is led by co-CEOs Susan Chapelle and Tim Moore, the former CEO of cannabis company Green Growth Brands Inc (OTC: GGBXF...